A multicentre randomised trial of single dose radiotherapy compared to ibandronate for localised metastatic bone pain.

Trial Profile

A multicentre randomised trial of single dose radiotherapy compared to ibandronate for localised metastatic bone pain.

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Dec 2015

At a glance

  • Drugs Ibandronic acid (Primary)
  • Indications Bone metastases; Prostate cancer
  • Focus Therapeutic Use
  • Acronyms RIB
  • Most Recent Events

    • 27 Sep 2011 Results presented at the 2011 European Multidisciplinary Cancer Congress.
    • 10 Jun 2010 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network.
    • 25 Mar 2010 United Kingdom Clinical Research Network reports acrual to date changed from 117% to 118%.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top